468 related articles for article (PubMed ID: 16495752)
1. Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension.
Chern CM; Hsu HY; Hu HH; Chen YY; Hsu LC; Chao AC
J Cardiovasc Pharmacol; 2006 Feb; 47(2):169-74. PubMed ID: 16495752
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive assessment of spontaneous baroreflex sensitivity and heart rate variability in patients with carotid stenosis.
Chao AC; Chern CM; Kuo TB; Chou CH; Chuang YM; Wong WJ; Hu HH
Cerebrovasc Dis; 2003; 16(2):151-7. PubMed ID: 12792173
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
4. Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects.
Geelen A; Zock PL; Swenne CA; Brouwer IA; Schouten EG; Katan MB
Am Heart J; 2003 Aug; 146(2):E4. PubMed ID: 12891211
[TBL] [Abstract][Full Text] [Related]
5. [Age dependency of heart rate variability, blood pressure variability and baroreflex sensitivity].
Wang SY; Zhang LF; Wang XB; Cheng JH
Space Med Med Eng (Beijing); 2000 Oct; 13(5):318-22. PubMed ID: 11894867
[TBL] [Abstract][Full Text] [Related]
6. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
7. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
[TBL] [Abstract][Full Text] [Related]
8. Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension.
Kishi T; Hirooka Y; Konno S; Sunagawa K
Clin Exp Hypertens; 2009 May; 31(3):241-9. PubMed ID: 19387900
[TBL] [Abstract][Full Text] [Related]
9. Relationships among spectral measures of baroreflex sensitivity and indices of cardiac vagal control.
Merritt MM; Sollers JJ; Evans MK; Zonderman AB; Thayer JF
Biomed Sci Instrum; 2003; 39():193-8. PubMed ID: 12724893
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats.
Nobre F; da Silva CA; Coelho EB; Salgado HC; Fazan R
Am J Hypertens; 2006 Oct; 19(10):1079-83. PubMed ID: 17027832
[TBL] [Abstract][Full Text] [Related]
11. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Devereux RB; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
[TBL] [Abstract][Full Text] [Related]
12. Heart rate and arterial pressure variability and baroreflex sensitivity in ovariectomized spontaneously hypertensive rats.
Dias da Silva VJ; Miranda R; Oliveira L; Rodrigues Alves CH; Van Gils GH; Porta A; Montano N
Life Sci; 2009 May; 84(21-22):719-24. PubMed ID: 19249314
[TBL] [Abstract][Full Text] [Related]
13. Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis.
Newton JL; Allen J; Kerr S; Jones DE
Liver Int; 2006 Mar; 26(2):197-202. PubMed ID: 16448458
[TBL] [Abstract][Full Text] [Related]
14. Spectral evaluation of aging effects on blood pressure and heart rate variations in healthy subjects.
Singh D; Vinod K; Saxena SC; Deepak KK
J Med Eng Technol; 2006; 30(3):145-50. PubMed ID: 16772217
[TBL] [Abstract][Full Text] [Related]
15. Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system.
Guzik P; Wykretowicz A; Krauze T; Piskorski J; Adamska K; Milewska A; Wesseling KH; Wysocki H
Hypertens Res; 2008 Mar; 31(3):443-53. PubMed ID: 18497463
[TBL] [Abstract][Full Text] [Related]
16. Restoration of baroreflex function in patients with end-stage renal disease after renal transplantation.
Rubinger D; Backenroth R; Sapoznikov D
Nephrol Dial Transplant; 2009 Apr; 24(4):1305-13. PubMed ID: 19145000
[TBL] [Abstract][Full Text] [Related]
17. Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients.
Guasti L; Petrozzino MR; Mainardi LT; Grimoldi P; Zanotta D; Garganico D; Diolisi A; Simoni C; Grandi AM; Gaudio G; Cerutti S; Venco A
Acta Cardiol; 2001 Oct; 56(5):289-95. PubMed ID: 11712824
[TBL] [Abstract][Full Text] [Related]
18. Influence of losartan and atenolol on memory function in very elderly hypertensive patients.
Fogari R; Mugellini A; Zoppi A; Derosa G; Pasotti C; Fogari E; Preti P
J Hum Hypertens; 2003 Nov; 17(11):781-5. PubMed ID: 14578918
[TBL] [Abstract][Full Text] [Related]
19. [Attempt to assess the risk of recurrence of life-threatening ventricular arrhythmia using simple non-invasive tests].
Daniłowicz-Szymanowicz L; Raczak G; Pinna GD; Maestri R; Szwoch M; Lubiński A; Kubica J; Swiatecka G
Pol Merkur Lekarski; 2004 Dec; 17(102):558-63. PubMed ID: 15771121
[TBL] [Abstract][Full Text] [Related]
20. Autonomic nervous system adjustment (ANSA) in patients with hypertension treated with enalapril.
Milovanovic B; Trifunovic D; Djuric D
Acta Physiol Hung; 2011 Mar; 98(1):71-84. PubMed ID: 21388933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
